Dallas Fort Worth Injury Lawyer Blog
As a Texas medical doctor and Dallas product liability, defective drug injury and wrongful death attorney I am providing this timely update for folks who have been injured by the use of Nuvaring contraceptive devices.
Take Home Message
Women who use combined contraceptive transdermal patches are at an increased risk of venous thrombosis about eight times that of non-users of hormonal contraception. Vaginal rings increased the risk of venous thrombosis 6.5 times compared with non-use of hormonal contraception.
According to medical studies and experts Nuvaring has almost 7 times the risk of venous thrombo-embolism, so tell me again, why is the Nuvaring still on the market?
NuvaRing Pulmonary Embolism and Deep Vein Thrombosis
NuvaRing Pulmonary Embolism and Deep Vein Thrombosis injury lawsuits filed in the federal court system have been consolidated before Judge Sippel for centralized pretrial proceedings in the U.S. District Court for the Eastern District of Missouri. All of the cases involve claims that women suffered serious and sometimes deadly, blood clots from side effects of NuvaRing.
NuvaRing Earliest Federal Trial Dates Set for July 2013
A small group of test lawsuits, known as bellwether cases, have been set for early trial dates in the federal NuvaRing multidistrict litigation. The first NuvaRing federal trial date will begin on July 8, 2013, and the plaintiff is a 33 year old woman who suffered a pulmonary embolism while using the birth control ring.
U.S. District Judge Rodney Sippel, overseeing the consolidated Nuvaring MDL litigation, issued an order for the first NuvaRing trial date to begin on July 8, 2013. This trial date is obviously subject to change depending on the progress of the trial preparation or if a settlement is announced.
The outcome of the early trial dates in the litigation are useful for the parties to determine how the juries are to respond to the lawsuits. If the plaintiffs are successful in their claims, a positive outcome will help pave the way to a global settlement. But, if NuvaRing settlements are not reached in these cases, the court may begin remanding cases back to federal district courts throughout the country for individual trials.
What is Nuvaring?
NuvaRing is a birth control device that releases female hormones through a plastic ring that is inserted into the vagina once a month. The ring releases estrogen ethinyl estradiol, and a “third-generation” progestin, known as etonogestrel. These hormones have been linked to an increased risk of blood clots and thrombotic events, such as pulmonary embolism, deep vein thrombosis, stroke and sudden death.
Read more here and visit our website for further information.